Accurate prediction of drug-induced liver injury using stem cell-derived populations

Area of Science:

• Hepatology
• Stem Cell Biology
• Toxicology

Background:

• Millions suffer from chronic liver disease, with limited treatment options beyond liver transplantation.
• Orthotopic liver transplantation is the only cure for end-stage liver disease but faces organ donor shortages.
• Developing predictive human systems is crucial for studying liver disease and preventing decompensated organ function.

Purpose of the Study:

• To create a scalable, predictive human cell-based model for liver injury.
• To utilize renewable human stem cells for generating functional hepatocytes.
• To establish a reliable system for assessing hepatotoxicity and modeling liver disease.

Main Methods:

• Human stem cells from defined genetic backgrounds were used.
• Cells were differentiated through developmental intermediates into hepatocyte populations.
• The model was validated by comparing stem cell-derived hepatocytes to primary adult hepatocytes using known hepatotoxins.

Main Results:

• Highly active, drug-inducible, and predictive human hepatocyte populations were generated.
• Stem cell-derived hepatocytes demonstrated equivalence to primary adult hepatocytes in response to hepatotoxins.
• A serum-free, scalable, and shippable cell-based model for predicting human liver injury was developed.

Conclusions:

• The developed stem cell-derived hepatocyte model accurately predicts potential human liver injury.
• This resource is valuable for human liver disease modeling and research.
• The model holds potential for future development of renewable cell-based therapies for liver conditions.